semaglutide with the least side effects Comparative safety and of and tirzepatide: Implications for clinical decision-making in obesity management Semaglutide Shines as Weight Loss

For patients with type 2 diabetes, stopping GLP-1 therapy usually leads to worsening glycemic control

When semaglutide loses strength, the medication may become weaker and may not provide the same blood sugar or weight-management benefits as expected

Acute events of gallbladder disease such as cholelithiasis or cholecystitis have been reported in GLP-1 receptor agonist trials and postmarketing

Satiety is the sensation of feeling full and satisfied after eating food, driven by hormones, such as GLP-1, that signal your brain that your stomach is full and your blood sugar is high

Most people do better with small, frequent meals and careful portion sizes